Sodium‐glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors on new‐onset overall cancer in Type 2 diabetes mellitus: A population‐based study

BACKGROUND: Cancer is currently the second leading cause of death globally. There is much uncertainty regarding the comparative risks of new‐onset overall cancer and pre‐specified cancer for Type 2 diabetes mellitus (T2DM) patients on sodium‐glucose cotransporter 2 inhibitors (SGLT2I) versus DPP4I....

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Cheuk To, Lakhani, Ishan, Chou, Oscar Hou In, Lee, Teddy Tai Loy, Dee, Edward Christopher, Ng, Kenrick, Wong, Wing Tak, Liu, Tong, Lee, Sharen, Zhang, Qingpeng, Cheung, Bernard Man Yung, Tse, Gary, Zhou, Jiandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278500/
https://www.ncbi.nlm.nih.gov/pubmed/37148547
http://dx.doi.org/10.1002/cam4.5927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278500/
https://www.ncbi.nlm.nih.gov/pubmed/37148547
http://dx.doi.org/10.1002/cam4.5927

Ejemplares similares